4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-056137
SVP and General Counsel sold 2,880 shares at an average $49.78 ($143,360)
- SVP and General Counsel acquired 2,880 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Taylor Stacy L · SVP and General Counsel
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-26 | Exercise or conversion : show line 1 in the form | +1,110 | $7.80 | $8,658 | 2,410 | D |
| 2020-10-26 | Exercise or conversion : show line 2 in the form | +1,770 | $6.55 | $11,594 | 4,180 | D |
| 2020-10-26 | Sale : show line 3 in the form | −618 | $49.11 | $30,350 | 3,562 | D |
| 2020-10-26 | Sale : show line 4 in the form | −2,262 | $49.96 | $113,010 | 1,300 | D |
| Open-market sales · 2,880 sh · avg $49.78 · $143,360 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-26 | Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) | −1,110 | 35,035 | D |
| 2020-10-26 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −1,770 | 30,105 | D |
Loading xslF345X03/doc4.xml…